What is Allogene Therapeutics's investment purchases?

Allogene Therapeutics (ALLO) reported investment purchases of $101.69M in Q1 2026.

How has Allogene Therapeutics's investment purchases changed year-over-year?

Allogene Therapeutics's investment purchases increased by 102.5% year-over-year, from $50.23M to $101.69M.

What is the long-term trend for Allogene Therapeutics's investment purchases?

Over 4 years (2021 to 2025), Allogene Therapeutics's investment purchases has grown at a -28.4% compound annual growth rate (CAGR), from $525.58M to $138.26M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Allogene Therapeutics ALLO Investment Purchases

Investment Purchases at other companies

Gilead SciencesGILD

$525M—

PrecigenPGEN

$33.87M+225%

CytomX TherapeuticsCTMX

$242.78M+1,127%

Immix Biopharma, Inc.IMMX

$7.77M+379%

Janux TherapeuticsJANX

$112.75M-69.6%

Iovance Biotherapeutics, Inc.IOVA

$56M-42.8%

Other financials

Income statement

See full

Revenue-—

Operating income-$46.1M+29.3%

Net income-$42.6M+28.7%

EPS (diluted)-$0.18+35.7%

Balance sheet

See full

Cash & equivalents$40.6M-23.0%

Total debt$81.1M-8.9%

Total equity$278.9M-27.6%

Total assets$396.0M-22.1%

Cash flow

See full

Operating cash flow-$12.9M+75.6%

CapEx$9.0K-90.9%

Free cash flow-$12.9M+75.6%

Valuation

See full

Market cap$711.02M+164%

Enterprise value$751.47M+146%

Profitability

See full

Operating margin-1,241,813.6%-2,018,140pp

Net margin-1,170,863.6%-2,007,890pp

FCF margin-913,609.1%-1,474,890pp

Returns & leverage

See full

Return on equity-52.3%-5.7pp

Debt / equity0.3×+0.1×

Current ratio9.6×-0.1×

Where this comes from

Reported directly by Allogene Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allogene Therapeutics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Allogene Therapeutics's investment purchases?: Allogene Therapeutics (ALLO) reported investment purchases of $101.69M in Q1 2026.
How has Allogene Therapeutics's investment purchases changed year-over-year?: Allogene Therapeutics's investment purchases increased by 102.5% year-over-year, from $50.23M to $101.69M.
What is the long-term trend for Allogene Therapeutics's investment purchases?: Over 4 years (2021 to 2025), Allogene Therapeutics's investment purchases has grown at a -28.4% compound annual growth rate (CAGR), from $525.58M to $138.26M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.